EJIFCC · 2024
Vitamin D Controversies in the Laboratory Medicine: A Review of Clinical Guidelines and Recommendations.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arrebola María Monsalud, Filella Xavier, Albaladejo-Oton María Dolores, Giménez Nuria, Serrano-Olmedo María Gemma, García-Martínez Rafael José, Bonet-Estruch Elena, Santamaría-González María, Pérez-Torrella Diana, Morell-García Daniel, Allué-Palacín Juan Antonio, Ruiz-Mínguez María Ángels, Castaño-López Miguel Ángel
Аннотация
A narrative review of the main guidelines and recommendations published from 2011 up to date about the status of vitamin D deficiency has been carried out. The objective of this review is to discuss the origin of the controversy about the status of this entity, as well as the evolution of the methodological aspects and clinical situations that require vitamin D screening. The results obtained indicate that the criteria defining vitamin D status, according to two studies published in 2011, the Institute of Medicine (IOM) recommendations and the Endocrine Society (ES) guidelines, regardless the affected population. Concerning the methodology used, progress has been made thanks to the Vitamin D Standardization Program (VDSP), although the most recent results from the external Vitamin D External Quality Program Assessment Scheme (DEQAS) indicate that there is still a significant bias among the different immunoassays available. In relation to the criteria for screening, an agreement is observed in the most recent publications.